Cardiol Therapeutics, Inc. (CRDL)
1.12
-0.03
(-2.61%)
USD |
NASDAQ |
Oct 23, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Price to Book Value : 7.663 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.663 |
| October 22, 2026 | 7.869 |
| October 21, 2026 | 8.005 |
| October 20, 2026 | 7.869 |
| October 19, 2026 | 7.526 |
| October 16, 2026 | 7.526 |
| October 15, 2026 | 7.869 |
| October 14, 2026 | 7.800 |
| October 13, 2026 | 8.211 |
| October 12, 2026 | 8.074 |
| October 09, 2026 | 8.416 |
| October 08, 2026 | 8.895 |
| October 07, 2026 | 9.032 |
| October 06, 2026 | 8.963 |
| October 05, 2026 | 9.032 |
| October 02, 2026 | 9.648 |
| October 01, 2026 | 10.67 |
| September 30, 2026 | 11.36 |
| September 29, 2026 | 11.56 |
| September 28, 2026 | 11.56 |
| September 25, 2026 | 11.70 |
| September 24, 2026 | 11.84 |
| September 23, 2026 | 12.11 |
| September 22, 2026 | 12.93 |
| September 21, 2026 | 12.73 |
| Date | Value |
|---|---|
| September 18, 2026 | 12.83 |
| September 17, 2026 | 12.73 |
| September 16, 2026 | 13.00 |
| September 15, 2026 | 12.66 |
| September 14, 2026 | 13.62 |
| September 11, 2026 | 13.65 |
| September 10, 2026 | 13.55 |
| September 09, 2026 | 15.63 |
| September 08, 2026 | 15.19 |
| September 04, 2026 | 15.05 |
| September 03, 2026 | 14.78 |
| September 02, 2026 | 14.85 |
| September 01, 2026 | 14.71 |
| August 31, 2026 | 13.51 |
| August 28, 2026 | 13.27 |
| August 27, 2026 | 14.10 |
| August 26, 2026 | 14.64 |
| August 25, 2026 | 13.68 |
| August 24, 2026 | 12.73 |
| August 21, 2026 | 12.73 |
| August 20, 2026 | 12.90 |
| August 19, 2026 | 13.41 |
| August 18, 2026 | 12.97 |
| August 17, 2026 | 12.32 |
| August 14, 2026 | 12.32 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 7.152 |
| NervGen Pharma Corp. | 4.609 |
| Milestone Pharmaceuticals, Inc. | 4.430 |
| Appili Therapeutics, Inc. | -- |
| Clearmind Medicine, Inc. | 0.1216 |
Price to Book Value Related Metrics
| Price | 1.12 |
| Earnings Yield | -22.11% |
| Market Cap | 129.79M |